DPP4 and diabetes mellitus: The reasons for this discrepancy remain uncertain, although clinical differences in the patients’ background, such as concomitant drugs and severity of diabetes and CV risk may, in part, influence the effectiveness of DPP-4 inhibitors on carotid atherosclerosis.